Categories
NCLEX EXAM
HESI ENTRANCE EXAM
HESI EXAM
ATI EXAM
NR & NUR Exams
Gizmos
AQA PAPERS AND MARK SCHEME
Exams and Certifications
NURS EXAM
PORTAGE LEARNING
NSG Exam
Ihuman Case Study
DMV
WGU EXAM
Study material
Quiz
Category
Tutor
Search
Login
Login
ATI Pharmacology Proctor 2019 SET 1
Helpsheet
×
Helpsheet
×
Report question problem
×
I think the answer is wrong
There are multiple correct answers
There is a typing error
Image or comprehension text is not display properly
Something else(please specify below)
Any more information
Question Number 4
A nurse is reviewing he laboratory results of a client who has a prescription for sodium polystyrene sulfonate (Kayexalate) every 6 hr. which of the following should the nurse report to the provider?
a. Creatinine 0.72 mg/dL
b. Sodium 138 mEq/L
c. Magnesium 2 mEq/L
d. Potassium 5.2 mEq/L - Hyperkalemia (serum potassium level greater than 5.0 mEq/L) increases the client risk for fatal cardiac dysrhythmias. Kayexalate is used to decrease the serum potassium level, so the PN should monitor the client's serum potassium level
✔ Correct Answer:
d. Potassium 5.2 mEq/L - Hyperkalemia (serum potassium level greater than 5.0 mEq/L) increases the client risk for fatal cardiac dysrhythmias. Kayexalate is used to decrease the serum potassium level, so the PN should monitor the client's serum potassium level
Count Down:
Related questions :
Modal title
×
...
.png){kind=logo}
.png)